NeuroPace reports Q1 2026 financial results in routine earnings release

NeuroPace filed a routine 8-K to announce its first quarter 2026 financial results through a press release dated May 12, 2026. This is standard quarterly disclosure practice—the 8-K itself does not contain the actual revenue, earnings, or other financial metrics, which are detailed in the attached press release exhibit. For retail investors, this filing signals that Q1 results are now public.

The key action item is to review the attached press release (Exhibit 99.1) for the actual numbers: revenue growth, net income or loss, cash position, and any forward guidance management provided. Pay particular attention to commentary on commercial adoption of NeuroPace's RNS System and any updates to the company's path to profitability. Watch for the full 10-Q filing in the coming weeks, which will provide detailed financial statements, management discussion and analysis, and risk factor updates that give fuller context to these headline results.